Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Cardiovascular diseases

Rheumatoid arthritis drug may reduce inflammation after stroke

Research into the use of an anti-arthritic drug to reduce brain injury following an ischemic stroke has shown promise; however, further research is needed.

3D CT scan of a person with a stroke

Source: Zephyr / Science Photo Library

Researchers investigated the effects of a drug form of interleukin-1 receptor antagonist (anakinra), used to treat rheumatoid arthritis, on acute ischemic stroke

The pro-inflammatory cytokine interleukin (IL)-1 plays a significant role in brain injury following ischemic stroke by inducing peripheral inflammatory mediators, such as IL-6. However, pre-clinical studies show its effects are reduced by the IL-1 receptor antagonist (IL-1Ra).

Researchers investigated the effects of a drug form of IL-1Ra (anakinra), used to treat rheumatoid arthritis, on acute ischemic stroke through a double-blind, randomised controlled trial[1].

The drug was administered subcutaneously, 100mg twice daily for 3 days, in 80 patients presenting within 5 hours of ischemic stroke onset. Levels of IL-6 and other plasma inflammatory markers were analysed at five time points, before, during and after treatment.

It was found that, over the three days, IL-1Ra significantly reduced levels of IL-6 and other inflammatory mediators.

IL-1Ra was found to be safe and well-tolerated, the researchers concluded in Stroke (22 March 2018). However, further experimental studies are required to investigate possible interactions with thrombolytic agents.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20204800

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • 3D CT scan of a person with a stroke

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.